TY - JOUR T1 - Trajectories: a framework for detecting temporal clinical event sequences from health data standardized to the OMOP Common Data Model JF - medRxiv DO - 10.1101/2021.11.18.21266518 SP - 2021.11.18.21266518 AU - Kadri Künnapuu AU - Solomon Ioannou AU - Kadri Ligi AU - Raivo Kolde AU - Sven Laur AU - Jaak Vilo AU - Peter R. Rijnbeek AU - Sulev Reisberg Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/11/19/2021.11.18.21266518.abstract N2 - Objective To develop a framework for identifying prominent clinical event trajectories from OMOP-formatted observational healthcare data.Methods A four-step framework based on significant temporal event pair detection is described and implemented as an open-source R package. It is used on a population-based Estonian dataset to first replicate a large Danish population-based study and second, to conduct a disease trajectory detection study for Type 2 Diabetes patients in the Estonian and Dutch databases as an example.Results As a proof of concept, we apply the methods in the Estonian database and provide a detailed breakdown of our findings. All Estonian population-based event pairs are shown. We compare the event pairs identified from Estonia to Danish and Dutch data and discuss the causes of the differences.Conclusions For the first time, there is a complete software package for detecting disease trajectories in health data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Estonian Research Council grants (PRG1095, RITA1/02-96-11), the European Union through the European Regional Development Fund grant EU48684, and the European Social Fund via IT Academy programme. The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Eesti bioeetika ja inimuuringute noukogu (EBIN) gave ethical approval for this work (approval 1.1-12/653)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript and supplementary material ER -